Agilent to acquire Biocare Medical for $950M, supercharging cancer diagnostics portfolio
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The new equipment will be installed at Codis’ 400,000-square-foot Haverhill facility and is expected to be operational by 2027
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
The first of four planned modules at the new plant is expected to come online by summer 2026
The document, published under the Accelerating Clinical Trials in the EU (ACT EU) initiative, sets out how trials should be conducted when health emergencies disrupt normal research operations
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
Subscribe To Our Newsletter & Stay Updated